gentamicin and tobramycin resistance by standardized disk testing. For Pseudomonas isolates, gentamicin resistance was 17.1% and tobramycin resistance was 2.8%. For other gram-negative bacilli, gentamicin resistance was 5.5% and tobramycin resistance was 5.4%. Seventy-four patients from whom gentamicin-resistant organisms were isolated from 1 January to 30 June 1976 were studied prospectively. These patients were elderly, had serious underlying diseases, and had received prior antibiotic therapy. Eleven patients carried gentamicin-resistant organisms at the time of transfer to our hospital from community hospitals or nursing homes. Of the 82 isolates from these 74 patients, 52 were from the urine. Pseudomonas was found most frequently (32 isolates), followed by Klebsiella (15 isolates), Enterobacter (10 isolates), Serratia (10 isolates), and Proteus (9 isolates). Only 3 of 32 Pseudomonas isolates caused symptomatic infection, while 16 of 50 other gram-negative bacilli were responsible for symptomatic infection. Although amikacin was the most active drug against gentamicin-resistant gram-negative bacilli and had not been used in our hospital at the time of this study, 25% of Pseudomonas and 18% of all gram-negative bacilli showed resistance to this aminoglycoside.
The emergence of gentamicin-resistant (Gr) gram-negative bacilli has been documented at a number of institutions (1, 3, 5, 7-9, 12, 13, 16, 17, 20) . Most studies, including those from our unit at the Cincinnati Veterans Administration Hospital, have emphasized the importance of Gr Pseudomonas aeruginosa (1, 3, 8, 9, 12) . Recent reports, however, have implicated Gr Enterobacteriaceae as a cause of serious nosocomial infections (5, 7, 13, 16, 17, 20) . In 1976, we instituted a program of prospective surveillance of all Gr aerobic gram-negative bacilli isolated at the Cincinnati Veterans Administration Hospital to determine the incidence of resistant organisms and their clinical significance. For comparison, the frequency of tobramycin resistance (Tr) was also monitored, since recent reports have documented an increase in Tr among gram-negative bacilli (5, 13 to determine the extent of cross-resistance and the effectiveness of the newer aminoglycosides.
MATERIALS AND METHODS
Routine antibiotic susceptibility testing of clinical isolates at the Cincinnati Veterans Administration Hospital was by the standard Kirby-Bauer disk method using media obtained from BBL, Cockeysville, Md., and antibiotic disks obtained from Pfizer, Inc., New York, N.Y. (2) . From 1 January to 31 December 1976, the susceptibility of aerobic gram-negative bacilli to gentamicin and tobramycin was tabulated monthly, and the frequency of resistance was calculated. All gram-negative bacilli were identified by the API system (Analytab Products, Inc., Plainview, N.Y.).
During the 6-month period from January to June 1976, all patients from whom G' gram-negative bacilli were isolated were prospectively followed throughout their hospitalization by the Infectious Diseases Service. Aspects followed included: whether the patient was transferred from a nursing home or from another hospital, ward location, source of specimens, underlying diseases, previous antibiotic therapy, prior instrumentation or surgical procedures, subsequent development of infection or colonization with other G' organisms, and outcome of infection or colonization. 918 GENTAMICIN-RESISTANT GRAM-NEGATIVE BACILLI Clinical evaluation was made on all patients as to whether the G' isolate caused infection, merely colonized the patient, or was a contaminant. The presence of fever and leukocytosis plus signs of inflammation at the site of isolation of the Gr organism were considered evidence of infection. Patients with urinary tract infections were subdivided into those who were symptomatic and those who were asymptomatic on the basis of clinical findings of dysuria, frequency, and suprapubic or costovertebral angle tenderness. Patients with colonization had none of these parameters present. A urinary tract isolate was deemed a contaminant if it occurred in an improperly collected urine specimen.
All gram-negative bacilli that were Gr and/or r by the disk method isolated during the calendar year 1976 were tested by the ICS agar dilution method (6) for their susceptibility to the following aminoglycosides: gentamicin, sisomicin, netilmicin, tobramycin, amikacin, kanamycin, and streptomycin. All aminoglycosides were tested simultaneously against a particular isolate. The concentrations tested were in twofold decreasing concentrations from 64 to 0.5 ,ug/ml. Clinically significant resistance was defined as minimal inhibitory concentration >4 ,ug/ml for gentamicin, sisomicin, netilmicin, and tobramycin and minimal inhibitory concentration >16 ,ug/ml for am;kacin, kanamycin, and streptomycin.
Procedures for bacterial mating and for selection of transconjugants were essentially as described (11, 12) . Four-hour matings of exponential cells were used. Antibiotics used were: streptomycin (Sm), tetracycline (Tc), gentamicin (G), carbenicillin (Cb), and tobramycin (T). Clinical isolates tested included 14 P. aeruginosa, with a resistance pattern of Smr, Tcr, G', Cbr, Tr, and four Pseudomonas species with antibiogram Smr, Tcr, Gr, Tr (two of these were also Cbr). Four facultative organisms tested included two Enterobacter cloacae and two Serratia marcescens, all with antibiogram Tcr, Gr, Tr, Cbr. Each strain was tested for single transfer of its Smr, Tcr, Gr, and T' markers in parallel platings using P. aeruginosa PL1 (11) For other gram-negative bacilli, the monthly rate of isolation of Gr and T organisms varied from 1.7 to 9.8% and from 1.7 to 8.1%, respectively (Fig. 2) . The mean incidence rates of Gr and TF for the entire year were 5.5% (202 of 3,706 isolates) and 5.4% (199 of 3,706 isolates), respectively.
Clinical surveillance. During the 6 months from January through June 1976, 121 Gr organisms were isolated from 74 patients. Excluding repeated isolates from the same patient, 82 Gr gram-negative bacilli were isolated from these 74 patients. The minimum inhibitory concentration of gentamicin against these 82 isolates was >4 ,tg/ml. Pseudomonas was the most frequent organism (32 isolates, of which 25 were P. aeruginosa), followed by Klebsiella (15 isolates), Enterobacter (10 isolates), Serratia (9 isolates), and Proteus (9 isolates). The remaining isolates were Acinetobacter (3), Providencia (2), Citrobacter (1), and E. coli (1) . Of the 82 isolates, 52 were from urine and 16 were from sputum.
Twenty-seven of the 82 isolates were responsible for 25 infections in the 74 patients (Table  1) . Of the 17 urinary tract infections, 9 were symptomatic. Two patients with urinary tract infections due to a Klebsiella and a Serratia became septicemic. There were seven patients with pneumonia and one with cholecystitis. Overall, only 3 were confirmed by the agar dilution minimal inhibitory concentrations. Sisomicin was more effective than gentamicin against Klebsiella, E. coli, and Citrobacter. Netilmicin was significantly more active than gentamicin against Klebsiella, Enterobacter, Serratia, and, to a lesser extent, E. coli and Citrobacter. Only 87.8% of Serratia were G', while 95.1% were Tr. Tobramycin had an advantage over gentamicin against Pseudomonas and perhaps Acinetobacter, but cross-resistance between gentamicin and tobramycin was almost complete for Enterobacteriaceae. Amikacin was the most effective aminoglycoside, but about 25% of Pseudomonas and 18% of all gram-negative bacilli in this study were resistant to it. Kanamycin was effective against some Proteus, Providencia, E. coli, and Citrobacter. Surprisingly, streptomycin was effective against more than half of all Klebsiella and Enterobacter and most Serratia.
Resistance plasmid studies. Eight of the Pseudomonas strains were mated with both E. coli C and P. aeruginosa PL1 as recipients. Seven were mated with strain PL1 only, while three were mated only with E. coli C. All of these tests were negative. By contrast, the two E. cloacae strains and one S. marcescens transferred multiple resistance pattems to E. coli C. None of these transferred to strain PL1, and the remaining S. marcescens failed to transfer resistance to either recipient. (10) , and a general trend toward increasing resistance has been noted since that timne (9, 18) . In our hospital, the rate of Gr for P. aeruginosa was 11.6% in 1976; this did not differ substantially from the frequency of isolation of Gr p. aeruginosa during 1972 and 1974 (1) . Similar high rates of GF P. aeruginosa have been found at other institutions (3, 13) . Over 44% of other Pseudomonas species were G , a finding not previously noted.
Resistance to tobramycin was much lower than to gentamicin for P. aeruginosa (0.5%) and other Pseudomonas species (12.4%). These figures probably represent, at least in part, reduced usage of tobramycin compared with gentamicin. In 1976, gentamicin was used 12-fold more than tobramycin in our hospital.
Recent studies have documented a rise in the isolation of Gr Enterobacteriaceae, especially Klebsiella and Serratia (7, 13, 16, 17, 20) . In our hospital 5.5% of all aerobic gram-negative bacilli, excluding Pseudomonas, were Gr. A variety of organisms isolated from different sites from patients in varying locations in the hospital contributed to this resistance rate. In other hospitals, abrupt increases of Gr among Enterobacteriaceae were associated with the spread of one organism throughout the hospital (7, 16, 20) . The pattern in our hospital was more consistent with low-level endemicity of Gr among Enterobacteriaceae as well as Pseudomonas.
Resistance transfer studies showed that antibiotic resistance in Pseudomonas from this hospital continues to be due to nonconjugative plasmids (11) . Studies on a more limited number of other'gram-negative bacilli showed the presence of conjugative plasmids.
Although the rate of GT among Enterobacteriaceae was one-third that found among Pseudomonas isolates, the Enterobacteriaceae caused significantly more symptomatic infection than the Pseudomonas. The only two cases of septicemia were due to a Klebsiella and a Serratia. Others have verified the greater incidence of Gr Klebsiella and Enterobacter infection when compared with Gr Pseudomonas (17) . Although Gr Pseudomonas appears to cause less symptomatic infection than G' Klebsiella, Gr Pseudomonas is fully capable of causing serious disease, as shown in this study as well as others (1, 13) and in an experimental rat model (19) . The clinical characteristics of patients developing infection or colonization with Gr organisms were similar to those described by others; this possibly reflects the fact that several of the previous studies have come from institutions very similar to ours (13, 17, 20) . The patients generally were elderly, with chronic underlying diseases, had received antibiotics prior to isolation of G' organisms, and had been hospitalized for a long period of time (1, 7, 13, 16, 20) . Although 69.6% of our patients had received antibiotics, only 25.3% had received gentamicin. Other studies have shown a stronger correlation between gentamicin usage and the subsequent isolation of Gr organisms (8) .
The true prevalence of Gr gram-negative bacilli throughout the community is not known, since most studies have been carried out at university medical centers. Our study does not provide direct evidence on this point, but does suggest that the prevalence in community hospitals and nursing homes may be significant. Of 71 patients with Gr organisms, 11 (15.5%) had these organisms at the time of transfer to our hospital from community hospitals or nursing homes. Two other patients readmitted to our hospital after discharge several weeks to months previously still carried Gr organisms acquired on the first hospitalization. Carriage of resistance transfer factors mediating kanamycin resistance has been documented in infants for as long as 1 year following discharge from the hospital, and spread to family members has also been found (4) . Further studies will have to be done to determine whether increasing resistance to gentamicin in the hospital environment will lead to increasing dissemination in the community. Practices at nursing homes, such as frequent use of catheters and antibiotics, should be studied in relation to the recovery of Gr organisms.
The in vitro susceptibility data showed that other aminoglycosides may be effective against Gr gram-negative bacilli. Tobramycin was effective against half of the Pseudomonas isolates but ineffective against other gram-negative bacilli. Netilmicin was particularly effective against Gr Klebsiella, Enterobacter, and Serratia. Although amikacin was very active, a large number of Gr gram-negative bacilli already have been reported to be resistant to amikacin. Our percentage of amikacin resistance of gram-negative bacilli (25% for Pseudomonas and 18% overall) was similar to figures reported by Price et al., who tested aminoglycoside-resistant gram-negative bacilli collected from around the world (15). Amikacin had not been given to any patients in our hospital at the time of this study. The surprising activity of streptomycin against Gr Klebsiella, Enterobacter, and Serratia is perhaps due to the fact that streptomycin is now seldom used in our hospital. Nosocomial infection due to Gr, streptomycin-susceptible Klebsiella has been reported recently (14) . ACKNOWLEDGMENTS Cheryl Glotzbecker and Dexter Balterman provided excellent technical assistance. The guidance of John C. Loper regarding the studies of resistance transfer factors is gratefully acknowledged.
